TNF and neoplasm: In general, there are three main directions to tackle this challenge therapeutically, which are (1) amplifying tumour antigen presentation, (2) inhibiting the action of T-cell inhibitory receptors, or (3) increasing tumour necrosis factor (TNF) signalling in tumours (Figure 3).